Eli Lilly says next-generation weight loss drug clears crucial obesity trial
RSS SUMMARY · AGGREGATED FROM CNBC
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Finland’s president says EU should expand to 40 states — including Canada
CNBC·4h ago·3 min read
Health
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
CNBC·4h ago·3 min read
US
Amazon engineers in Seattle slam employer for building AI data centers while laying off 30,000 staffers
CNBC·9h ago·3 min read
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·10h ago·3 min read
Related
On this beat
Business
Walmart CEO addresses the concerns of many longtime shoppers
THE STREET·1h ago·3 min read
Business
A Delta Air Lines Flight Attendant Just Retired After 67 Years. These 3 Words Mattered Most
INC·1h ago·3 min read
Business
Cities Are Blocking Data Centers at Record Rates. Here’s the Lesson for All Leaders
INC·1h ago·3 min read
Business
Russia prunes Armenian rose trade ahead of election
FT·5h ago·3 min read